Crossmark

Impact of risk scores in outcome of patients with myeloid neoplasms after allogeneic stem cell transplant

Crossref DOI link: https://doi.org/10.1016/j.medcle.2021.05.023

Published Print: 2022-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Fernández-Caballero, Mariana

Jiménez Lorenzo, Maria-Josefa

Morgades de la Fe, Mireia

Ferrà Coll, Christelle

Vives Polo, Susana

Abril Sabater, Laura

Navarro Ferrando, José-Tomás

Ribera Santasusana, Josep-Maria
License Information

Text and Data Mining valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01

stm-asf valid from 2022-05-01
More Information

This article is maintained by: Elsevier

Article Title: Impact of risk scores in outcome of patients with myeloid neoplasms after allogeneic stem cell transplant

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2021.05.023

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2021.05.025

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.